# Grace Therapeutics, Inc.: Form 8-K, filed Aug 16, 2024

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2024-08-16
- Accepted by EDGAR: Aug 16, 2024, 16:05 ET
- Period: 2024-08-12
- Accession: 0000950170-24-098049
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000095017024098049/acst-20240812.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000095017024098049/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000095017024098049/acst-20240812.htm

Filed Aug 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-098049. Last ingested by Listed: Oct 26, 2026, 18:07 ET. No prices; not investment advice.